These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26777910)

  • 21. Long-term follow-up of nephrotoxicity in rats administered both melamine and cyanuric acid.
    Yasui T; Kobayashi T; Okada A; Hamamoto S; Hirose M; Mizuno K; Kubota Y; Umemoto Y; Kawai N; Tozawa K; Gao B; Kohri K
    BMC Res Notes; 2014 Feb; 7():87. PubMed ID: 24507656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the renal effects of experimental feeding of melamine and cyanuric acid to fish and pigs.
    Reimschuessel R; Gieseker CM; Miller RA; Ward J; Boehmer J; Rummel N; Heller DN; Nochetto C; de Alwis GK; Bataller N; Andersen WC; Turnipseed SB; Karbiwnyk CM; Satzger RD; Crowe JB; Wilber NR; Reinhard MK; Roberts JF; Witkowski MR
    Am J Vet Res; 2008 Sep; 69(9):1217-28. PubMed ID: 18764697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrotoxicity of mala fide melamine: modern era milk scandal.
    Lattupalli R; Yee J; Kolluru A
    ScientificWorldJournal; 2008 Oct; 8():949-50. PubMed ID: 18836663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melamine nephrotoxicity: an emerging epidemic in an era of globalization.
    Bhalla V; Grimm PC; Chertow GM; Pao AC
    Kidney Int; 2009 Apr; 75(8):774-9. PubMed ID: 19212415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Astilbin improves potassium oxonate-induced hyperuricemia and kidney injury through regulating oxidative stress and inflammation response in mice.
    Wang M; Zhao J; Zhang N; Chen J
    Biomed Pharmacother; 2016 Oct; 83():975-988. PubMed ID: 27522260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathological changes in rat model of urinary calculus induced by melamine].
    Shen Y; Sun N; Wang GN; He LJ; Jia LQ; Wang Y; Xiao HZ; Lü RF
    Zhonghua Er Ke Za Zhi; 2011 Sep; 49(9):690-5. PubMed ID: 22176905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Derivation of a melamine oral reference dose (RfD) and drinking-water total allowable concentration.
    Bhat VS; Ball GL; McLellan CJ
    J Toxicol Environ Health B Crit Rev; 2010 Jan; 13(1):16-50. PubMed ID: 20336578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-nephrolithic potential of catechin in melamine-related urolithiasis via the inhibition of ROS, apoptosis, phospho-p38, and osteopontin in male Sprague-Dawley rats.
    Li X; Wu G; Shang P; Bao J; Lu J; Yue Z
    Free Radic Res; 2015 Oct; 49(10):1249-58. PubMed ID: 26059739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect and mechanism of total saponin of Dioscorea on animal experimental hyperuricemia.
    Chen GL; Wei W; Xu SY
    Am J Chin Med; 2006; 34(1):77-85. PubMed ID: 16437741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreasing effect of allantoxanamide, a hyperuricemic agent on renal functions in rats.
    Yonetani Y; Iwaki K; Ogawa Y
    Jpn J Pharmacol; 1987 Sep; 45(1):37-43. PubMed ID: 3119902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioxidant responses and renal crystal formation in rainbow trout treated with melamine administered individually or in combination with cyanuric acid.
    Pacini N; Prearo M; Abete MC; Brizio P; Dörr AJ; Reimschuessel R; Andersen W; Gasco L; Righetti M; Elia AC
    J Toxicol Environ Health A; 2013; 76(8):491-508. PubMed ID: 23721584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of subchronic toxicity of pet food contaminated with melamine and cyanuric acid in rats.
    Chen KC; Liao CW; Cheng FP; Chou CC; Chang SC; Wu JH; Zen JM; Chen YT; Liao JW
    Toxicol Pathol; 2009 Dec; 37(7):959-68. PubMed ID: 19801503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening of the toxic effects of a high melamine dose on the biochemical hematological and histopathological investigations in male rats.
    El Rabey HA; Al-Sieni AI; Majami AA
    Toxicol Ind Health; 2014 Nov; 30(10):950-63. PubMed ID: 24253415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of oxonic acid-induced hyperuricemia on mesenteric artery tone and cardiac load in experimental renal insufficiency.
    Kurra V; Vehmas T; Eräranta A; Jokihaara J; Pirttiniemi P; Ruskoaho H; Tokola H; Niemelä O; Mustonen J; Pörsti I
    BMC Nephrol; 2015 Mar; 16():35. PubMed ID: 25886588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melamine-induced urolithiasis in a Drosophila model.
    Chen WC; Lin WY; Chen HY; Chang CH; Tsai FJ; Man KM; Shen JL; Chen YH
    J Agric Food Chem; 2012 Mar; 60(10):2753-7. PubMed ID: 22352299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melamine Impairs Renal and Vascular Function in Rats.
    Tian XY; Wong WT; Lau CW; Wang YX; Cheang WS; Liu J; Lu Y; Huang H; Xia Y; Chen ZY; Mok CS; Lau CM; Huang Y
    Sci Rep; 2016 Jun; 6():28041. PubMed ID: 27324576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal oxidative stress induced by long-term hyperuricemia alters mitochondrial function and maintains systemic hypertension.
    Cristóbal-García M; García-Arroyo FE; Tapia E; Osorio H; Arellano-Buendía AS; Madero M; Rodríguez-Iturbe B; Pedraza-Chaverrí J; Correa F; Zazueta C; Johnson RJ; Lozada LG
    Oxid Med Cell Longev; 2015; 2015():535686. PubMed ID: 25918583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of losartan on expression of monocyte chemoattractant protein-1 (MCP-1) in hyperuricemic nephropathy rats.
    Yu S; Ren Q; Wu W
    J Recept Signal Transduct Res; 2015; 35(5):458-61. PubMed ID: 25830624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Podocyte Injury and Albuminuria in Experimental Hyperuricemic Model Rats.
    Asakawa S; Shibata S; Morimoto C; Shiraishi T; Nakamura T; Tamura Y; Kumagai T; Hosoyamada M; Uchida S
    Oxid Med Cell Longev; 2017; 2017():3759153. PubMed ID: 28337250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency.
    Eräranta A; Kurra V; Tahvanainen AM; Vehmas TI; Kööbi P; Lakkisto P; Tikkanen I; Niemelä OJ; Mustonen JT; Pörsti IH
    J Hypertens; 2008 Aug; 26(8):1661-8. PubMed ID: 18622246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.